
Friday, May 16, 2025 8:20:57 PM
Recent HALO News
- Halozyme to Participate at Upcoming Investor Conferences • PR Newswire (US) • 05/28/2025 08:05:00 PM
- Halozyme Announces Bristol Myers Squibb Received European Commission Approval for Subcutaneous Opdivo® (nivolumab) Co-Formulated with ENHANZE® Across Multiple Solid Tumor Indications • PR Newswire (US) • 05/28/2025 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2025 08:08:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 08:06:31 PM
- HALOZYME RAISES 2025 FINANCIAL GUIDANCE RANGES AND REPORTS STRONG FIRST QUARTER 2025 RESULTS • PR Newswire (US) • 05/06/2025 08:01:00 PM
- Halozyme to Participate in the BofA Securities 2025 Healthcare Conference • PR Newswire (US) • 05/05/2025 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2025 08:11:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2025 08:08:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2025 08:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2025 08:06:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2025 08:04:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/02/2025 08:02:32 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/28/2025 09:18:36 PM
- Halozyme to Report First Quarter 2025 Financial and Operating Results • PR Newswire (US) • 04/28/2025 12:30:00 PM
- Halozyme Announces argenx Received Positive CHMP Opinion for VYVGART® (efgartigimod alfa) Subcutaneous Injection with ENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) • PR Newswire (US) • 04/28/2025 11:30:00 AM
- Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation • PR Newswire (US) • 04/24/2025 12:30:00 PM
- Halozyme Announces FDA Approval of argenx's VYVGART® Hytrulo Prefilled Syringe Co-Formulated with ENHANZE® for Self-Injection for Generalized Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy • PR Newswire (US) • 04/10/2025 10:15:00 PM
- European Commission Approved Subcutaneous DARZALEX® (daratumumab)-based Quadruplet Regimen for the Treatment of Patients with Newly Diagnosed Multiple Myeloma, Regardless of Transplant Eligibility • PR Newswire (US) • 04/09/2025 12:45:00 PM
- European Commission Approves Subcutaneous RYBREVANT® (amivantamab) Co-Formulated with ENHANZE® for the Treatment of Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer • PR Newswire (US) • 04/07/2025 01:29:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2025 10:32:16 PM
- Halozyme Announces Bristol Myers Squibb Received Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) with ENHANZE® Across Multiple Solid Tumor Indications • PR Newswire (US) • 03/31/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/21/2025 08:03:19 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/18/2025 08:17:06 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/18/2025 08:14:31 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/18/2025 08:10:39 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM